AIFA
-
News
AIOM: AIFA decisions without consulting clinicians. It's chaos at the Italian Medicines Agency
Aiom: "Ready to take a step back with Aifa, but the resignation remains" "At the moment you are only in contact with Palù, In the commissions ...
Leggi » -
News
Agenas also becomes an agency for digital health
New Agenas statute, the body also becomes an agency for digital health Federfarma - 10 June 2023 Agenas, the National Agency for…
Leggi » -
News
In 2022, 89 new drugs approved in Europe: the EMA report
There are 89 new drugs recommended for approval by the European Medicines Agency (EMA) during 2022; Of…
Leggi » -
News
AIFA. Summary of payments under the Pharmaceutical expenditure plan for direct purchases for the year 2021 (payback) - Update of 10/05/2023
Update to 10 May 2023 The Companies communicate that they have paid the Regions and Autonomous Provinces over 1.027 billion…
Leggi » -
News
AIFA. Questions & Answers relating to the Online Service "IMS - Scientific Representatives"
To facilitate the pharmaceutical companies users of the "IMS - Scientific Representatives" Online Service, we provide, in the form of Questions &…
Leggi » -
News
AIFA. Report on the timing of drug pricing and reimbursement procedures in the five-year period 2018-2022
The Italian Medicines Agency (AIFA) has conducted an update of the analysis on the authorization times of the pricing and reimbursement procedures…
Leggi » -
News
The EU proposals for the revision of pharmaceutical legislation
Incentives to pharma industries and lists of 'critical' drugs, the EU proposals for the revision of pharmaceutical legislation Brussels reveals the…
Leggi » -
News
AIFA, 'Horizon Scanning' report. In 2022, 89 new medicines were authorized in the EU
In Europa, nel corso del 2022, sono stati autorizzati 89 nuovi medicinali, di cui 48 contenenti nuove sostanze attive, 8…
Leggi » -
News
AIFA. Summary of payments as a Shelf (payback) of pharmaceutical expenditure direct purchases for the year 2021 - Update of 03/30/2023
Update as at 30 March 2023 The Companies communicate that they have paid the Regions and Autonomous Provinces over 1.023 billion…
Leggi » -
News
The review of the EU's pharmaceutical strategy is (still) postponed
Slitta (ancora) la revisione della strategia farmaceutica dell’Ue Il pacchetto di riforma previsto il 29 marzo, dopo un primo rinvio…
Leggi »